Paper36969713
Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview.
Stevens D and 2 others. Curr Treat Options Neurol, 2022. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview. Papers, record 36969713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969713
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AR078340 | NIAMS NIH HHS | United States | R01AR078340 | PubMed and NIH | NIH RePORTER |
| U24 NS107210 | NINDS NIH HHS | United States | U24NS107210 | PubMed and NIH | NIH RePORTER |
| UL1 TR001414 | NCATS NIH HHS | United States | UL1TR001414 | PubMed and NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21232767 | Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening. | J Pediatr | 2011 | https://conductscience.org/library/papers/21232767 | PubMed |
| 2 | 31796685 | Advancements in AAV-mediated Gene Therapy for Pompe Disease. | J Neuromuscul Dis | 2020 | https://conductscience.org/library/papers/31796685 | PubMed |
| 3 | 23570273 | Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes. | Hum Gene Ther | 2013 | https://conductscience.org/library/papers/23570273 | PubMed |
| 4 | 26830551 | Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD). | J Inherit Metab Dis | 2016 | https://conductscience.org/library/papers/26830551 | PubMed |
| 5 | 16702877 | Pompe disease diagnosis and management guideline. | Genet Med | 2006 | https://conductscience.org/library/papers/16702877 | PubMed |
| 6 | 31522955 | Antibody-Mediated Enzyme Therapeutics and Applications in Glycogen Storage Diseases. | Trends Mol Med | 2019 | https://conductscience.org/library/papers/31522955 | PubMed |
| 7 | 31794466 | Myotonic Muscular Dystrophies. | Continuum (Minneap Minn) | 2019 | https://conductscience.org/library/papers/31794466 | PubMed |
| 8 | 28856460 | Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies. | J Neurol | 2017 | https://conductscience.org/library/papers/28856460 | PubMed |
| 9 | 16426990 | Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. | Lancet Neurol | 2006 | https://conductscience.org/library/papers/16426990 | PubMed |
| 10 | 33451932 | Effect of long term enzyme replacement therapy in late onset Pompe disease: A single-centre experience. | Neuromuscul Disord | 2021 | https://conductscience.org/library/papers/33451932 | PubMed |
| 11 | 21825984 | Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches. | Curr Opin Neurol | 2011 | https://conductscience.org/library/papers/21825984 | PubMed |
| 12 | 34400331 | Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies. | Mol Ther | 2021 | https://conductscience.org/library/papers/34400331 | PubMed |
| 13 | 21543987 | Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy. | Genet Med | 2011 | https://conductscience.org/library/papers/21543987 | PubMed |
| 14 | 32134266 | Discovery and Development of Small-Molecule Inhibitors of Glycogen Synthase. | J Med Chem | 2020 | https://conductscience.org/library/papers/32134266 | PubMed |
| 15 | 29162675 | Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum. | Pediatrics | 2017 | https://conductscience.org/library/papers/29162675 | PubMed |
| 16 | 10078739 | A diagnostic protocol for adult-onset glycogen storage disease type II. | Neurology | 1999 | https://conductscience.org/library/papers/10078739 | PubMed |
| 17 | 10482961 | Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. | Eur J Hum Genet | 1999 | https://conductscience.org/library/papers/10482961 | PubMed |
| 18 | 25296331 | Reproducibility and absolute quantification of muscle glycogen in patients with glycogen storage disease by 13C NMR spectroscopy at 7 Tesla. | PLoS One | 2014 | https://conductscience.org/library/papers/25296331 | PubMed |
| 19 | 33073007 | The First Year Experience of Newborn Screening for Pompe Disease in California. | Int J Neonatal Screen | 2020 | https://conductscience.org/library/papers/33073007 | PubMed |
| 20 | 22676651 | A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations. | Orphanet J Rare Dis | 2012 | https://conductscience.org/library/papers/22676651 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42871814 | Evaluation of Pompe Disease from a Broad and Systemic Perspective. | J Clin Pract Res | 2026 | https://conductscience.org/library/papers/42871814 | PubMed |
| 42633127 | GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42633127 | PubMed |
| 42353063 | Carrier Frequencies of Medically Actionable Pathogenic Variants in the Russian Population. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353063 | PubMed |
| 41653352 | Measuring What Matters to Patients with Pompe Disease: A Review of Clinical Outcome Assessments for Capturing Treatment Benefits of Innovative Novel Therapies. | Adv Ther | 2026 | https://conductscience.org/library/papers/41653352 | PubMed |
| 41622854 | Longitudinal characterization of Gaac.1826dupA mice reveals the cardiac, myopathic and biochemical phenotypes of Pompe disease. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/41622854 | PubMed |
| 41586257 | Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications. | Exp Biol Med (Maywood) | 2025 | https://conductscience.org/library/papers/41586257 | PubMed |
| 41536902 | Early initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe disease. | Genet Med Open | 2026 | https://conductscience.org/library/papers/41536902 | PubMed |
| 41463072 | Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis. | Biomedicines | 2025 | https://conductscience.org/library/papers/41463072 | PubMed |
| 41326286 | New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment. | Neurotherapeutics | 2026 | https://conductscience.org/library/papers/41326286 | PubMed |
| 41317268 | Current Achievements in Gene Therapy Strategies and Delivery Systems in Preclinical and Clinical Models of Heart Failure. | Curr Heart Fail Rep | 2025 | https://conductscience.org/library/papers/41317268 | PubMed |
| 41286962 | The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data. | Orphanet J Rare Dis | 2025 | https://conductscience.org/library/papers/41286962 | PubMed |
| 41229640 | When the Diaphragm Fails: Visual Hallucinations Due to Isolated Respiratory Muscle Weakness as a First Manifestation of Late-Onset Pompe Disease. | Eur J Case Rep Intern Med | 2025 | https://conductscience.org/library/papers/41229640 | PubMed |
| 41161912 | The Mythology of Polymyositis. | Rheum Dis Clin North Am | 2025 | https://conductscience.org/library/papers/41161912 | PubMed |
| 41158907 | Anaesthetic Management of Advanced Late-Onset Pompe Disease: Challenges in a Major Abdominal Surgery. | Cureus | 2025 | https://conductscience.org/library/papers/41158907 | PubMed |
| 41148004 | A retrospective cohort study describing the disease burden in patients with Pompe disease treated with enzyme replacement therapy in the United States. | J Neuromuscul Dis | 2026 | https://conductscience.org/library/papers/41148004 | PubMed |
| 41078577 | Molecular characterization of a novel synonymous variant in a Mexican patient with Pompe disease. | Mol Genet Metab Rep | 2025 | https://conductscience.org/library/papers/41078577 | PubMed |
| 41049133 | Transcriptional profiling reveals glucose-dependent regulation of COL13A1 mRNA in Pompe patients: Prospect for a novel disease mechanism. | Genes Dis | 2026 | https://conductscience.org/library/papers/41049133 | PubMed |
| 40981304 | Umbilical Cord Blood Sampling for Newborn Screening of Pompe Disease and the Detection of a Novel Pathogenic Variant and Pseudodeficiency Variants in an Asian Population. | Int J Neonatal Screen | 2025 | https://conductscience.org/library/papers/40981304 | PubMed |
| 40947720 | Pompe Disease: A Review of Diagnosis, Molecular Genetics, and Treatment Management. | Curr Cardiol Rev | 2026 | https://conductscience.org/library/papers/40947720 | PubMed |
| 40801056 | Latest Advancements in Treatment Options for Infantile-Onset Pompe Disease: A Comprehensive Narrative Review. | Clin Med Insights Pediatr | 2025 | https://conductscience.org/library/papers/40801056 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD63 | 967 | PubTator's text mining | https://conductscience.org/library/genes/967 | NCBI Gene |
| CMPK1 | 51727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| GAA | 2548 | PubTator's text mining | https://conductscience.org/library/genes/2548 | NCBI Gene |
| IFI30 | 10437 | PubTator's text mining | https://conductscience.org/library/genes/10437 | NCBI Gene |
| IGF2R | 3482 | PubTator's text mining | https://conductscience.org/library/genes/3482 | NCBI Gene |
| ITGA7 | 3679 | PubTator's text mining | https://conductscience.org/library/genes/3679 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36969713
GET https://conductscience.org/api/papers/v1/36969713/references?page=2